Strengths and weaknesses of a stepped wedge cluster randomized design: Its application in a colorectal cancer follow-up study

Journal of Clinical Epidemiology

Volumn 67, Issue 4, 2014, Pages 454-461

  Zhan, Zhuozhao ^a   Van Den Heuvel, Edwin R ^a   Doornbos, Peter M ^a   Burger, Huib ^a   Verberne, Charlotte J ^a   Wiggers, Theo ^a   De Bock, Geertruida H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Clinical trial; Cluster analysis; Colorectal cancer; Epidemiological research design; Randomized controlled trial; Stepped wedge design

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RECURRENCE; COLORECTAL CANCER; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE COST; HUMAN; INFORMED CONSENT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MOTIVATION; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN;

CLINICAL TRIAL; CLUSTER ANALYSIS; COLORECTAL CANCER; EPIDEMIOLOGICAL RESEARCH DESIGN; RANDOMIZED CONTROLLED TRIAL; STEPPED WEDGE DESIGN;

CARCINOEMBRYONIC ANTIGEN; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC RESEARCH DESIGN; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84896709351     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.10.018     Document Type: Article

References (25)

1. D. Schwartz, and J. Lellouch Explanatory and pragmatic attitudes in therapeutical trials J Clin Epidemiol 62 2009 499 505
2. N.A. Patsopoulos A pragmatic view on pragmatic trials Dialogues Clin Neurosci 13 2011 217 224
3. S. Treweek, and M. Zwarenstein Making trials matter: pragmatic and explanatory trials and the problem of applicability Trials 10 2009 37
4. D.G. Altman Random allocation. Practical statistics for medical research 1st ed. 1991 Chapman & Hall London, UK 85 90
5. S.J. Pocock Methods of randomization. Clinical trials: a practical approach 7th ed. 1983 John Wiley & Sons Ltd. New York 66 89
6. D.J. Torgerson Contamination in trials: is cluster randomisation the answer? BMJ 322 2001 355 357
7. The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group Cancer Res 47 1987 5782 5787
8. M.A. Hussey, and J.P. Hughes Design and analysis of stepped wedge cluster randomized trials Contemp Clin Trials 28 2007 182 191
9. C.A. Brown, and R.J. Lilford The stepped wedge design: a systematic review BMC Med Res Methodol 6 2006 54
10. N.D. Mdege, M.S. Man, C.A. Taylor Nee Brown, and D.J. Torgerson Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation J Clin Epidemiol 64 2011 936 948
11. J. Hughes, R.L. Goldenberg, C.M. Wilfert, M. Valentine, K.S. Mwinga, and J.S.A. Stringer Design of the HIV prevention trials network (HPTN) protocol 054: a cluster randomized crossover trial to evaluate combined access to Nevirapine in developing countries UW Biostatistics Working Paper Series 195 2003
12. W. Woertman, E. De Hoop, M. Moerbeel, S.U. Zuidema, D.L. Gerritsen, and S. Teerenstra Stepped wedge designs could reduces the required sample size in cluster randomized trials J Clin Epidemiol 66 2013 752 758
13. D. Kotz, M. Spigt, I.C.W. Arts, R. Crutzen, and W. Viechtbauer Use of the stepped wedge design cannot be recommended: a critical appraisal and comparison with the classic cluster randomized controlled trial design J Clin Epidemiol 65 2012 1249 1252
14. H.J. Staab, F.A. Anderer, E. Stumpf, and R. Fischer Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer Am J Surg 136 1978 322 327
15. M. Jeffery, B.E. Hickey, and P.N. Hider Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database Syst Rev 1 2007 CD002200
16. G.Y. Locker, S. Hamilton, J. Harris, J.M. Jessup, N. Kemeny, and J.S. Macdonald et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 24 2006 5313 5327
17. M.J. Duffy, A. van Dalen, C. Haglund, L. Hansson, E. Holinski-feder, and R. Klapdor et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use Eur J Cancer 43 2007 1348 1360
18. J.J. Tjandra, and M.K. Chan Follow-up after curative resection of colorectal cancer: a meta-analysis Dis Colon Rectum 50 2007 1783 1799
19. I. Grossmann, C. Verberne, G.H. de Bock, K. Havenga, I. Kema, and J. Klaase et al. The role of high frequency dynamic threshold (HiDT) serum carcinoembryonic antigen (CEA) measurements in colorectal cancer surveillance: a (revisited) hypothesis paper Cancers (Basel) 3 2011 2302 2315
20. C.J. Verberne, C.H. Nijboer, G.H. de Bock, I. Grossmann, T. Wiggers, and K. Havenga Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer BMC Med Inform Decis Mak 12 2012 14
21. D.J. Bentrem, R.P. Dematteo, and L.H. Blumgart Surgical therapy for metastatic disease to the liver Ann Rev Med 56 2005 139 156
22. J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series Ann Thorac Surg 84 2007 324 338
23. H. Kobayashi, H. Mochizuki, K. Sugihara, T. Morita, K. Kotake, and T. Teramoto et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery 141 2007 67 75
24. J.C. van Houwelingen Roaming through methodology. III. Randomization at the level of the physicians Ned Tijdschr Geneeskd 142 1998 1662 1665
25. P.L. Ergina, J.A. Cook, J.M. Blazeby, I. Boutron, P.A. Clavien, and B.C. Reeves et al. Challenges in evaluating surgical innovation Lancet 374 2009 1097 1104